Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PDL1 Detection Set (Risk Free)

ELISA, FACS, ICC, IF, IHC (p), WB Reactivity: Human ELISA, FACS, ICC, IF, IHC (p), WB unconjugated Extracellular Domain Host: Mouse Monoclonal
Catalog No. ABIN6251785
  • Target See all PD-L1 products
    PD-L1 (CD274 (PD-L1))
    Binding Specificity
    Extracellular Domain
    Reactivity
    Human
    Host
    • 2
    • 1
    • 1
    Mouse
    Clonality
    Monoclonal
    Application
    ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
    Brand
    Risk-Free™
    Characteristics
    Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2. PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells. This suggests that PD-L1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts.
    Purification
    Antibodies are supplied as protein A purified IgG1.
    Components
    PD-L1 Antibody [4F2]
    PD-L1 Antibody [8E12]
    PD-L1 Antibody [6H10]
    PD-L1 Antibody [2D6]
    PD-L1 Antibody [1F11]
    PD-L1 Antibody [1D7]
    Immunogen
    PD-L1 antibodies were raised against the extracellular domain of human PD-L1.
    Isotype
    IgG1
  • Comment

    Risk-Free™ antibodies are monoclonal antibodies made to improve in vitro studies.
    Unlike antibodies developed using proteins made in yeast or bacteria, Risk-Free™ antibodies are developed with antigens expressed in mammalian cell lines, giving the most native post-translational modifications to the protein.
    These antibodies have the following advantages:
    - Antibodies are developed against mammalian-expressed, post-translationally modified recombinant proteins.
    - Multiple antibodies per target allows the user to choose the best antibody for their application
    - Available individually or as a set
    - Risk-Free™ means they are rigorously tested and guaranteed to work for their designated applications:
    - ELISA
    - Flow Cytometry
    - Immunoblot
    - Immunohistochemistry
    - Immunocytochemistry
    - Immunofluorescence

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    PBS containing 0.02 % sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Target
    PD-L1 (CD274 (PD-L1))
    Alternative Name
    PDL1 (PD-L1 Products)
You are here:
Support